PreludeDx: Pat Whitworth

PreludeDx has appointed Pat Whitworth as chief medical officer. He has more than 30 years of clinical expertise and has served as breast surgical oncologist and director at the Nashville Breast Center, medical director of Aptitude Health, and associate professor in the surgery department of the University of Tennessee. Additionally, he was chair of the board of directors for the American Society of Breast Surgeons. Laguna Hills, California-based PreludeDx aims to launch a multiomic test for determining which early-stage breast cancer patients may benefit from radiotherapy.